Burkhardt Glen

VP, Human ResourcesPhaseBio Pharmaceuticals Inc (PHAS) · full profile →Form 4 · filed May 24, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$13K
Net Open-Market Flow
-$13K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 20, 2021Grant(A)4K$2.80$11K4K
May 20, 2021Sell(S)4K$3.29$13K0

Transaction Codes

A
Grant / award
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001169245-21-000046) within minutes of acceptance. Every field above traces to the original document. Verify it directly: